Journal Menu
- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
Guest Editors: Eduard Parellada, Dawn I. Velligan, Robin Emsley, and Werner Kissling- Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia, Eduard Parellada, Dawn I. Velligan, Robin Emsley, and Werner Kissling
Volume 2012 (2012), Article ID 318535, 3 pages - Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons, Borah Kim, Sang-Hyuk Lee, Yen Kuang Yang, Jong-Il Park, and Young-Chul Chung
Volume 2012 (2012), Article ID 560836, 8 pages - Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection, Christian Asseburg, Michael Willis, Mickael Löthgren, Niko Seppälä, Mika Hakala, and Ulf Persson
Volume 2012 (2012), Article ID 791468, 9 pages - Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia: A Clinical Perspective, Radovan Přikryl, Hana Přikrylová Kučerová, Michaela Vrzalová, and Eva Češková
Volume 2012 (2012), Article ID 764769, 7 pages - Treatment Adherence with Early Prescription of Long-Acting Injectable Antipsychotics in Recent-Onset Schizophrenia, Annie Viala, Françoise Cornic, and Marie-Noëlle Vacheron
Volume 2012 (2012), Article ID 368687, 5 pages - Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review, Simon Zhornitsky and Emmanuel Stip
Volume 2012 (2012), Article ID 407171, 12 pages